These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19117135)

  • 1. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.
    Beer J; Wagner CC; Zeitlinger M
    AAPS J; 2009 Mar; 11(1):1-12. PubMed ID: 19117135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotics and protein binding].
    Tillement JP; Chauvelot L
    Therapie; 1978; 33(3):235-49. PubMed ID: 356336
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible approaches to the simulation of antibiotic kinetics and the determination of antibacterial activity in vitro.
    Tosch W; Schnell R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():117-20. PubMed ID: 3980322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of plasma protein binding on antimicrobial activity using time-killing curves.
    Zeitlinger MA; Sauermann R; Traunmüller F; Georgopoulos A; Müller M; Joukhadar C
    J Antimicrob Chemother; 2004 Nov; 54(5):876-80. PubMed ID: 15472003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standardization of the methods of determining microorganism sensitivity to antibiotics. The effect of the size of the inoculate on the results of determining microorganism sensitivity to antibiotics and its standardization].
    Givental' NI; Ved'mina EA
    Antibiotiki; 1978 Jun; 23(6):513-20. PubMed ID: 677838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUCAST Definitive Document E.DEF 2.1, August 2000: Determination of antimicrobial susceptibility test breakpoints.
    European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
    Clin Microbiol Infect; 2000 Oct; 6(10):570-2. PubMed ID: 11168058
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods for the rapid determination of microbial sensitivity to antibiotics].
    D'iakov SI; Il'na NIu; Lebedeva IK
    Antibiotiki; 1983 Jul; 28(7):545-54. PubMed ID: 6354076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Nishida M; Mine Y; Matsubara T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1972 Oct; 25(10):582-93. PubMed ID: 4567453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of a method for the quantitative assessment of microorganism sensitivity to antibiotics using discs. The study of different nutrient media for determining microorganism sensitivity to antibiotics].
    Rezvan SP; Chaĭkovskaia SM; Semenov SM; Galkina TP; Dmitrova LI
    Antibiotiki; 1978 Jan; 23(1):50-3. PubMed ID: 623447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic pharmacokinetic indices and their significance in working out antibacterial therapy regimens and predicting their efficacy].
    Navashin SM; Navashin PS
    Antibiot Khimioter; 1993; 38(10-11):26-34. PubMed ID: 8085889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies in the effect of protein binding on beta-lactam antibiotics.
    Bakhtiar M; Selwyn S
    Chemioterapia; 1987 Jun; 6(2 Suppl):54-6. PubMed ID: 3509494
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokinetics.
    Craig WA; Vogelman B
    Am J Med; 1984 Jul; 77(1B):24-8. PubMed ID: 6380283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin.
    Burian A; Wagner C; Stanek J; Manafi M; Böhmdorfer M; Jäger W; Zeitlinger M
    J Antimicrob Chemother; 2011 Jan; 66(1):134-7. PubMed ID: 21044975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic kinetics and dynamics for the clinician.
    Nicolau DP; Quintiliani R; Nightingale CH
    Med Clin North Am; 1995 May; 79(3):477-95. PubMed ID: 7752723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antibiotic susceptibility testing trial organised as part of the United Kingdom national external microbiological quality assessment scheme.
    Snell JJ; Brown DF; Gardner PS
    J Clin Pathol; 1982 Nov; 35(11):1169-76. PubMed ID: 7142426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
    Schuetz AN
    Clin Infect Dis; 2014 Sep; 59(5):698-705. PubMed ID: 24867792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents.
    European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID)
    Clin Microbiol Infect; 2000 Sep; 6(9):503-8. PubMed ID: 11168186
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminoglycoside antibiotics. Selected aspects of antibacterial activity and pharmacology.
    Rosenthal SL
    N Y State J Med; 1975 Mar; 75(4):535-47. PubMed ID: 1056513
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamics of antimicrobial drugs.
    Levison ME
    Infect Dis Clin North Am; 2004 Sep; 18(3):451-65, vii. PubMed ID: 15308272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.